The event is web-based. You do not need to download anything. Also the possibility to participate in the live chat is anonymous or your names are only visible to the speakers. This training is implemented according to the EU-DSGVO! The team of speakers would be very pleased about your interest and participation. You can register…Details
We are pleased to inform you that our latest product developments are now available on request. You can find further information here.
Due to the corona pandemic, POTS, CFS/ME, CRPS diagnostics are currently only performed in our laboratory at approximately 2 to 3-week intervals. The next sample determination is scheduled for October 22th, 2020. Please send us your sample with the completed request form (important: email address and signature). For guide of blood preparation, please click here!…Details
Prof. Dr. Jonas Bergquist, University of Uppsala, Sweden, investigated antibodies against adrenergic receptors (a1, a2, b1, b2, b3) and acetylcholine muscarinergic receptors (M1-5) in two Swedish CFS/ME cohorts. For M3R-Ab and M4R-Ab a significant increase in antibody levels was found in CFS/ME patients compared to controls in both cohorts, for b1-adr-R-Ab and b2-adr-R-Ab only in…Details
The nationwide “Network for Pharma Solutions” (NetPhaSol), consists of 50 competent partners. The 20 research institutions and 30 companies including CellTrend are covering the entire value chain in drug discovery and development. The “Network for Pharma Solutions” (NetPhaSol) starts campaign for networking and cooperation Are you looking for qualified partner for your project? Are…Details
Can silicone breast implants trigger autoimmune diseases? Since the introduction of silicone breast implants in 1962 breast augmentation is the most common cosmetic surgery. But until today there were a lot of studies made which deal with the impairment of health and higher rates of several autoimmune diseases after silicone implants insertion. The condition is…Details
CellTrend passed the monitoring audit for ISO 13485! Our management system fulfills the required standards for development and production of immunologic assays, cell culture systems and in-vitro-diagnostics again!
Human papillomavirus (HPV) infection promotes uterine and cervical cancers. In 2010, HPV vaccines were introduced worldwide. Since then case series of suspected adverse effects after HPV vaccination have been reported from several countries and the symptoms described by independent researchers are similar. In this study, autoantibodies against diverse Gprotein coupled receptors in the serum of…Details